Dr Martin Main

Martin has extensive expertise in early-stage drug discovery, having previously led the Discovery Biology UK department at AstraZeneca which had the remit of reagent generation and assay development for Oncology and CNS projects. In his current role as Chief Scientist at Medicines Discovery Catapult (MDC), Martin is accountable for the development and delivery of MDC’s science strategy, with oversight of laboratory, informatics and partnership activities. MDC’s science strategy is focussed on cellular sciences, target engagement, biomarkers and drug delivery & biodistribution and utilises a range of technologies including mass spectrometry, microscopy, spatial tissue analysis and pre-clinical imaging. An ion channel electrophysiologist by training, Martin has worked in the pharmaceutical industry for 25 years, at Merck, GlaxoSmithKline and AstraZeneca. Martin holds a PhD in Cardiac Physiology from St George’s, University of London, and a BSc in Physiology from the University of Manchester.